Monitor Hormone Therapy for Safety by Dr. Lynn August
Excesses of estrogen and progesterone – including excesses of molecules and compounds with estrogen-like and progesterone-like effects – interfere with cell and tissue function. Interference with cell and tissue function will lead to symptoms and disease, sooner or later. This is why some women have unwanted effects when taking a hormone therapy.
Estrogen and progesterone are lipids. They are anti-inflammatory lipids. Anti-inflammatory lipids in excess interfere with cell and tissue oxygen, electrolyte and mineral metabolisms. When considering hormone replacement it is adviseable to ask whether a woman already has excess anti-inflammatory lipids; or whether, by adding hormones, she will now have excess anti-inflammatory lipids.
If a patient’s Anti-Free radical Activity (Anti-FRA) score is high, i.e. above 35, this woman already has excess anti-inflammatory lipids. If adding hormones, or supplements with hormonal effects, decreases the Anti-FRA score, she is deficient in hormones. The hormones have replaced the other compensatory anti-inflammatory lipids, lipids that do not have the necessary hormonal effects. The hormones will be benefically as hormones AND will improve overall health. If adding hormones, however, does not result in a decrease in a high Anti-FRA, or if hormones increase the Anti-FRA, this woman now has excess anti-inflammatory lipids. She therefore is at risk for developing unwanted effects, sooner or later.
The other score to monitor in all patients taking hormone therapy is the Free Radical Index(FRA). Free radicals are produced by pro-inflammatory lipids. Testosterone is a pro-inflammatory lipid. The same holds true for testosterone and the FRA score as described above for estrogen and progesterone and the Anti-FRA score. If a man or woman’s high FRA decreases with testosterone therapy the therapy is safe and beneficial. However, if a high FRA score does not decrease, or if the FRA increases, testosterone therapy alone is contraindicated. Combinations of hormones will have their unique composite effects in each individual. It is possible testosterone in combination with other hormones will not increase the FRA score in some individuals even when testosterone alone does result in an increase.
Use both the Anti-FRA score and the FRA score before and during (and after, if applicable) hormone therapy…to minimize risk and optimize benefits. These scores monitor hormone therapies for menopause, bone density, contraception, body building, heart disease, cancer and more. The Anti-FRA and FRA scores allow you to use all hormones, in varying combinations and in both women and men, to optimize health and natural aging.
:: Hormone Support ::
Dr. Lynne August, of Greenfield NH, is the founder and director of Health Equations. She received her Medical Degree from Washington University School of Medicine in 1973. She combined conventional and holistic medicines in private practice for ten years and soon after, founded Health Equations. For almost thirty years, Dr. August has been researching significant influences on health… diet, soil, water, agriculture, food processing and environmental exposures. The inspiration in Lynne’s clinical practice and research comes largely from her experience as a Clinical Researcher at the Institute of Applied Biology in New York. There, Dr. August assisted Scientific Director Emanuel Revici M.D. in research on non-toxic therapeutic lipids. She also draws upon her training and practice in Ayurveda. Prior to her work at the Institute of Applied Biology, Lynne served on the board of the American Holistic Medical Association, researched hyperinsulinism and diabetes and served as the staff physician at a multi-disciplinary research center for children with developmental needs. Dr. August has been widely published. She lectures at physician seminars throughout North America and Europe and hosts seminars for clinical health professionals.